Literature DB >> 11375994

Reversibility of scrapie-associated prion protein aggregation.

M A Callahan1, L Xiong , B Caughey.   

Abstract

During the course of the transmissible spongiform encephalopathy diseases, a protease-resistant ordered aggregate of scrapie prion protein (PrP(Sc)) accumulates in affected animals. From mechanistic and therapeutic points of view, it is relevant to determine the extent to which PrP(Sc) formation and aggregation are reversible. PrP(Sc) solubilized with 5 m guanidine hydrochloride (GdnHCl) was unfolded to a predominantly random coil conformation. Upon dilution of GdnHCl, PrP refolded into a conformation that was high in alpha-helix as measured by CD spectroscopy, similar to the normal cellular isoform of PrP (PrP(C)). This provided evidence that PrP(Sc) can be induced to revert to a PrP(C)-like conformation with a strong denaturant. To examine the reversibility of PrP(Sc) formation and aggregation under more physiological conditions, PrP(Sc) aggregates were washed and resuspended in buffers lacking GdnHCl and monitored over time for the appearance of soluble PrP. No dissociation of PrP from the PrP(Sc) aggregates was detected in aqueous buffers at pH 6 and 7.5. The effective solubility of PrP was <0.7 nm. Treatment of PrP(Sc) with proteinase K (PK) before the analysis did not enhance the dissociation of PrP from the PrP(Sc) aggregates. Treatment with 2.5 m GdnHCl, which partially and reversibly unfolds PrP(Sc), caused only limited dissociation of PrP from the aggregates. The PrP that dissociated from the aggregates over time was entirely PK-sensitive, like PrP(C), whereas all of the aggregated PrP was partially PK-resistant. PrP also dissociated from aggregates of protease-resistant PrP generated in a cell-free conversion reaction, but only if treated with GdnHCl. Overall, the results suggest that PrP aggregation is not appreciably reversible under physiological conditions, but dissociation and refolding can be enhanced by treatments with GdnHCl.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11375994     DOI: 10.1074/jbc.M103629200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Octapeptide repeat insertions increase the rate of protease-resistant prion protein formation.

Authors:  Roger A Moore; Christian Herzog; John Errett; David A Kocisko; Kevin M Arnold; Stanley F Hayes; Suzette A Priola
Journal:  Protein Sci       Date:  2006-02-01       Impact factor: 6.725

2.  Separation of native prion protein (PrP) glycoforms by copper-binding using immobilized metal affinity chromatography (IMAC).

Authors:  Henrik Müller; Alexander Strom; Gerhard Hunsmann; Andreas W Stuke
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

Review 3.  Potential roles for prions and protein-only inheritance in cancer.

Authors:  H Antony; A P Wiegmans; M Q Wei; Y O Chernoff; K K Khanna; A L Munn
Journal:  Cancer Metastasis Rev       Date:  2012-06       Impact factor: 9.264

4.  Amyloid features and neuronal toxicity of mature prion fibrils are highly sensitive to high pressure.

Authors:  Driss El Moustaine; Veronique Perrier; Isabelle Acquatella-Tran Van Ba; Filip Meersman; Valeriy G Ostapchenko; Ilia V Baskakov; Reinhard Lange; Joan Torrent
Journal:  J Biol Chem       Date:  2011-02-25       Impact factor: 5.157

5.  Effect of glycans and the glycophosphatidylinositol anchor on strain dependent conformations of scrapie prion protein: improved purifications and infrared spectra.

Authors:  Gerald S Baron; Andrew G Hughson; Gregory J Raymond; Danielle K Offerdahl; Kelly A Barton; Lynne D Raymond; David W Dorward; Byron Caughey
Journal:  Biochemistry       Date:  2011-05-03       Impact factor: 3.162

Review 6.  Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions.

Authors:  Byron Caughey; Gerald S Baron; Bruce Chesebro; Martin Jeffrey
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

7.  Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays.

Authors:  Jason M Wilham; Christina D Orrú; Richard A Bessen; Ryuichiro Atarashi; Kazunori Sano; Brent Race; Kimberly D Meade-White; Lara M Taubner; Andrew Timmes; Byron Caughey
Journal:  PLoS Pathog       Date:  2010-12-02       Impact factor: 6.823

8.  The importance of prions.

Authors:  Glenn C Telling
Journal:  PLoS Pathog       Date:  2013-01-31       Impact factor: 6.823

Review 9.  Prion propagation in vitro: are we there yet?

Authors:  Chongsuk Ryou; Charles E Mays
Journal:  Int J Med Sci       Date:  2008-11-11       Impact factor: 3.738

10.  Reversible unfolding of infectious prion assemblies reveals the existence of an oligomeric elementary brick.

Authors:  Angélique Igel-Egalon; Mohammed Moudjou; Davy Martin; Alexandra Busley; Tina Knäpple; Laetitia Herzog; Fabienne Reine; Nad'a Lepejova; Charles-Adrien Richard; Vincent Béringue; Human Rezaei
Journal:  PLoS Pathog       Date:  2017-09-07       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.